LYMPHOTOXIN/LIGHT PATHWAY REGULATES ATHEROSCLEROSIS AND LIPID HOMEOSTASIS

J. Lo,Y. Wang,A. Tumanov,M. Bamji,Z. Yao,C. Reardon,G. Getz,Y. Fu
DOI: https://doi.org/10.1016/S1567-5688(08)70148-X
2008-01-01
Atherosclerosis Supplements
Abstract:The lymphotoxin (LT)-pathway is a unique constituent branch of the Tumor Necrosis Superfamily (TNFSF). Use of LT is a critical mechanism by which fetal innate lymphoid cells regulate lymphoid organogenesis. Within recent years, adult innate lymphoid cells have been discovered to utilize this same pathway to regulate IL-22 and IL-23 production for host defense. Notably, genetic studies have linked polymorphisms in the genes encoding LTα to several phenotypes contributing to metabolic syndrome. The role of the LT-pathway may lay the foundation for a bridge between host immune response, microbiota, and metabolic syndrome. The contribution of the LT-pathway to innate lymphoid cell function and metabolic syndrome will be visited in this review.
What problem does this paper attempt to address?